{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:05:43Z","timestamp":1781780743027,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ft\u0131rma Kurumu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007613","name":"Ankara University","doi-asserted-by":"publisher","award":["18\\u202FL0217001"],"award-info":[{"award-number":["18\\u202FL0217001"]}],"id":[{"id":"10.13039\/100007613","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.taap.2024.117219","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T16:11:04Z","timestamp":1736007064000},"page":"117219","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["The effects of UGT1A4 and ABCB1 polymorphisms on clozapine and N- desmethyl clozapine plasma levels in Turkish schizophrenia patients"],"prefix":"10.1016","volume":"495","author":[{"given":"Fezile","family":"Ozdemir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve Demirbugen","family":"Oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenan Can","family":"Tok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emrah","family":"Dural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yagmur","family":"K\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Gumustas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Baskak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Sinan","family":"Suzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2024.117219_bb0005","series-title":"Ruh Sa\u011fl\u0131\u011f\u0131 ve Hastal\u0131klar\u0131","first-page":"309","article-title":"Psikiyatrik hastaliklarda somatik tedaviler","author":"Ak","year":"2014"},{"issue":"6","key":"10.1016\/j.taap.2024.117219_bb0010","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/0004563216686377","article-title":"Quantification of the steady-state plasma concentrations of clozapine and N-desmethylclozapine in Japanese patients with schizophrenia using a novel HPLC method and the effects of CYPs and ABC transporters polymorphisms","volume":"54","author":"Akamine","year":"2017","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.taap.2024.117219_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5\u00ae)","author":"American Psychiatric Association","year":"2013"},{"issue":"4","key":"10.1016\/j.taap.2024.117219_bb0020","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3109\/00048679809068332","article-title":"The clinical use of plasma clozapine levels","volume":"32","author":"Bell","year":"1998","journal-title":"Austr. N. Z. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.taap.2024.117219_bb0025","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/FPC.0b013e3283331637","article-title":"A pharmacogenetics study of the human glucuronosyltransferase UGT1A4","volume":"19","author":"Benoit-Biancamano","year":"2009","journal-title":"Pharmacogenet. Genomics"},{"issue":"4","key":"10.1016\/j.taap.2024.117219_bb0030","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/2045125315588647","article-title":"Concomitant use of two or more antipsychotic drugs is common in Sweden","volume":"5","author":"Bergendal","year":"2015","journal-title":"Therap. Adv. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.taap.2024.117219_bb0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/hup.1191","article-title":"Factors affecting interindividual differences in clozapine response: a review and case report","volume":"26","author":"Bersani","year":"2011","journal-title":"Hum. Psychopharmacol."},{"issue":"22","key":"10.1016\/j.taap.2024.117219_bb0040","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.1002\/j.1460-2075.1996.tb01001.x","article-title":"Homologues of the human multidrug resistance genes MRP and MDR contribute to heavy metal resistance in the soil nematode Caenorhabditis elegans","volume":"15","author":"Broeks","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.taap.2024.117219_bb0045","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1158\/0008-5472.CAN-09-4582","article-title":"Glucuronidation genotypes and nicotine metabolic phenotypes: importance of functional UGT2B10 and UGT2B17 polymorphisms","volume":"70","author":"Chen","year":"2010","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.taap.2024.117219_bb0050","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2217\/pgs.09.51","article-title":"ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients","volume":"10","author":"Consoli","year":"2009","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.taap.2024.117219_bb0055","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/14740338.2020.1698545","article-title":"The clozapine to norclozapine ratio: a narrative review of the clinical utility to minimize metabolic risk and enhance clozapine efficacy","volume":"19","author":"Costa-Dookhan","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.taap.2024.117219_bb0060","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/17425255.2023.2221849","article-title":"The potential role of POR*28 and CYP1A2*F genetic variations and lifestyle factors on clozapine and N-DesmethylClozapine plasma levels in Schizopherina patients","volume":"19","author":"Demirbugen Oz","year":"2023","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2024.117219_bb0065","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/00498254.2015.1078522","article-title":"Involvement of oxidative stress and mitochondrial\/lysosomal cross-talk in olanzapine cytotoxicity in freshly isolated rat hepatocytes","volume":"46","author":"Eftekhari","year":"2016","journal-title":"Xenobiotica"},{"issue":"4","key":"10.1016\/j.taap.2024.117219_bb0070","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/hep.20131","article-title":"Variation of hepatic glucuronidation: novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4","volume":"39","author":"Ehmer","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.taap.2024.117219_bb0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.9740\/mhc.2015.03.068","article-title":"A review of the clinical utility of serum clozapine and norclozapine levels","volume":"5","author":"Ellison","year":"2015","journal-title":"Mental Health Clin."},{"issue":"8","key":"10.1016\/j.taap.2024.117219_bb0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/FPC.0b013e328354026b","article-title":"Glucuronidation of the second-generation antipsychotic clozapine and its active metabolite N-desmethylclozapine. Potential importance of the UGT1A1 a (TA) 7TAA and UGT1A4 L48V polymorphisms","volume":"22","author":"Erickson-Ridout","year":"2012","journal-title":"Pharmacogenet. Genomics"},{"issue":"2","key":"10.1016\/j.taap.2024.117219_bb0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/JCP.0000000000001653","article-title":"Clozapine: dose, sex, ethnicity, smoking habit, age, body weight, and plasma clozapine and N -Desmethylclozapine (Norclozapine) concentrations in clinical practice","volume":"43","author":"Flanagan","year":"2023","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.taap.2024.117219_bb0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jpsychires.2012.01.012","article-title":"Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population","volume":"46","author":"Fujii","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.taap.2024.117219_bb0095","first-page":"1","article-title":"Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs","volume":"6","author":"Gallhofer","year":"1996","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.taap.2024.117219_bb0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00228-009-0783-8","article-title":"Carriers of the UGT1A4 142T> G gene variant are predisposed to reduced olanzapine exposure\u2014an impact similar to male gender or smoking in schizophrenic patients","volume":"66","author":"Ghotbi","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"6","key":"10.1016\/j.taap.2024.117219_bb0105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0031-1286287","article-title":"AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011","volume":"44","author":"Hiemke","year":"2011","journal-title":"Phrmacopsychiatry"},{"issue":"7","key":"10.1016\/j.taap.2024.117219_bb0110","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","article-title":"Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo","volume":"97","author":"Hoffmeyer","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.taap.2024.117219_bb0115","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pscychresns.2020.111128","article-title":"The relationship between plasma levels of clozapine and N-desmethyclozapine as well as M1 receptor polymorphism with cognitive functioning and associated cortical activity in schizophrenia","volume":"303","author":"Kir","year":"2020","journal-title":"Psychiatry Res. Neuroimaging"},{"issue":"4","key":"10.1016\/j.taap.2024.117219_bb0120","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/YIC.0000000000000065","article-title":"Gene polymorphisms potentially related to the pharmacokinetics of clozapine: a systematic review","volume":"31","author":"Krivoy","year":"2016","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.117219_bb0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.4088\/JCP.v60n0108","article-title":"Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics","volume":"60","author":"Lane","year":"1999","journal-title":"J. Clin. Psychiatry"},{"issue":"1","key":"10.1016\/j.taap.2024.117219_bb0130","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1365-2125.2003.02007.x","article-title":"Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications","volume":"57","author":"Mangoni","year":"2004","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2024.117219_bb0135","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1055\/s-2007-979481","article-title":"Improvement of cognitive function in schizophrenic patients receiving clozapine or zotepine: results from a double-blind study","volume":"30","author":"Meyer-Lindenberg","year":"1997","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.taap.2024.117219_bb0140","series-title":"Handbook of Analytical Validation","author":"Michael","year":"2012"},{"issue":"3","key":"10.1016\/j.taap.2024.117219_bb0145","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.taap.2024.117219_bb0150","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1124\/dmd.104.002576","article-title":"UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation","volume":"33","author":"Mori","year":"2005","journal-title":"Drug Metab. Dispos."},{"issue":"2","key":"10.1016\/j.taap.2024.117219_bb0155","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/JCP.0b013e31820f9152","article-title":"Ultra-resistant schizophrenia is not associated with the multidrug-resistant transporter 1 (MDR1) gene rs1045642 variant","volume":"31","author":"Mouaffak","year":"2011","journal-title":"J. Clin. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.117219_bb0160","article-title":"Genetic and clinical factors affectng plasma clozapine concentration","volume":"17","author":"Olsson","year":"2015","journal-title":"Prim. Care Compan. CNS Disord."},{"issue":"9","key":"10.1016\/j.taap.2024.117219_bb0165","first-page":"638","article-title":"Schizophrenia: overview and treatment options","volume":"39","author":"Patel","year":"2014","journal-title":"PT"},{"key":"10.1016\/j.taap.2024.117219_bb0170","first-page":"235","article-title":"ABCB1 and ABCC1 single- nucleotide polymorphisms in patients treated with clozapine","volume":"10","author":"Piatkov","year":"2017","journal-title":"Pharmacogenomics Pers. Med."},{"issue":"1","key":"10.1016\/j.taap.2024.117219_bb0175","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.jcp.0000106221.36344.4d","article-title":"Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients","volume":"24","author":"Rostami- Hodjegan","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.taap.2024.117219_bb0180","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.psychres.2018.06.070","article-title":"The impact of delay in clozapine initiation on treatment outcomes in patients with treatment-resistant schizophrenia: a systematic review","volume":"268","author":"Shah","year":"2018","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.taap.2024.117219_bb0185","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/JCP.0b013e3181acc372","article-title":"ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine","volume":"29","author":"Sirot","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.taap.2024.117219_bb0190","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1517\/17425255.2015.1075003","article-title":"Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update","volume":"11","author":"Sriretnakumar","year":"2015","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"1","key":"10.1016\/j.taap.2024.117219_bb0195","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12863-016-0434-x","article-title":"Association between ABCB1 C3435T polymorphism and breast cancer risk: a Moroccan case-control study and meta-analysis","volume":"17","author":"Tazzite","year":"2016","journal-title":"BMC Genet."},{"key":"10.1016\/j.taap.2024.117219_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2008-2231-21-28","article-title":"Hepatoprotective effect of silyamarin in individuals chronically exposed to hydrogen sulfide; modulating influence of TNF-\u03b1 cytokine genetic polymorphism","volume":"21","author":"Mandegary","year":"2013","journal-title":"DARU J. Pharm. Sci."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24004186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24004186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:10:40Z","timestamp":1777457440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24004186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":40,"alternative-id":["S0041008X24004186"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.117219","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of UGT1A4 and ABCB1 polymorphisms on clozapine and N- desmethyl clozapine plasma levels in Turkish schizophrenia patients","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.117219","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117219"}}